— 
| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 50mg | 3 bottle | £129.06 | £387.17 Best Price Popular | |
| 50mg | 2 bottle | £138.17 | £276.33 | |
| 50mg | 1 bottle | £151.83 | £151.83 |
Disclaimer: This page provides general information about Sprycel (dasatinib). It is not a substitute for medical advice from a doctor or pharmacist. Always follow the advice of your healthcare team.
Sprycel is the brand name for the medicine dasatinib. It is a type of cancer therapy known as a tyrosine kinase inhibitor. It works by blocking certain enzymes that help cancer cells grow and survive.
The medicine is prescribed under the supervision of a clinician. Whether Sprycel is appropriate for you depends on your medical history and the type of cancer being treated. In the United Kingdom, its use is guided by professional medical assessment and official guidance, and it may require a prescription depending on local rules.
Sprycel is available as tablets to be taken by mouth. It is intended for adults and some children under specialist care, as determined by your doctor. Do not use Sprycel if you were not prescribed it for your own condition.
The tablets should be taken exactly as advised by your healthcare team. Do not share your medication with others. If you have questions about whether Sprycel is right for you, discuss them with your doctor or a pharmacist.
Always refer to the patient information leaflet that comes with the medicine for full details on what Sprycel is and how it works. Your clinician may adjust treatment based on how you respond to therapy and any side effects you experience.
Sprycel is used to treat certain blood cancers under medical supervision. It may be prescribed for conditions such as chronic myeloid leukaemia (CML) or certain forms of acute lymphoblastic leukaemia (ALL), depending on the individual case and treatment plan.
Treatment with Sprycel can be part of a broader plan that includes other medicines or therapies. Your clinician will tailor the plan to your specific needs and may adjust treatment over time.
How Sprycel is used, including how often it is taken and for how long, depends on factors such as the type of cancer, how well the cancer responds to treatment, and how well you tolerate the medicine. Regular monitoring by your healthcare team is an important part of therapy.
If you have questions about the exact indications for your condition, speak with your healthcare professional. They can explain why Sprycel has been chosen for you and what to expect during treatment.
Sprycel contains dasatinib, which belongs to a class of medicines known as tyrosine kinase inhibitors. It targets several enzymes that can be overactive in certain cancer cells, helping those cells to grow and divide unchecked.
By blocking these enzymes, Sprycel aims to slow or stop the growth of cancer cells while allowing normal cells to continue functioning. The exact effect can vary between individuals and between different cancer types.
The action of Sprycel is part of a broader treatment approach and is monitored with blood tests and other assessments. Your doctor will explain what these tests mean in your situation.
As with other cancer medicines, Sprycel may affect healthy cells as well as cancer cells. This is why regular monitoring and management of side effects are important parts of therapy.
Take Sprycel exactly as prescribed by your doctor. It is taken by mouth as tablets. Do not change your dose or stop taking the medicine without medical advice.
Swallow the tablets whole with a glass of water. Do not chew, crush or break the tablet unless your clinician has told you to do so. You can take Sprycel with or without food, depending on the plan agreed with your doctor.
If you miss a dose, contact your clinician for advice. Do not double up or take extra doses unless told to do so by a healthcare professional. If you are unsure about what to do after a missed dose, seek guidance from your pharmacist or doctor.
Keep a current list of all medicines you take, including over‑the‑counter products and herbal supplements, and show it to your healthcare team. Some medicines can interact with Sprycel or affect how well it works.
Storage: Store Sprycel at room temperature in its original packaging. Keep it away from moisture and heat, and out of the reach of children. Do not use medicine that is past its expiry date.
Do not take Sprycel if you are allergic to dasatinib or any ingredient in the tablet. An allergic reaction can be serious and requires immediate medical attention.
Pregnant or breastfeeding individuals should discuss risks with their clinician before starting Sprycel. Contraception and careful planning are important during treatment, as advised by your doctor.
If you have significantly reduced blood cell counts, severe liver problems, heart problems, or serious lung or breathing conditions, your clinician may decide that Sprycel is not suitable for you. Your doctor will weigh potential benefits against risks in your situation.
Always tell your healthcare team about all medicines you take, including prescription, over‑the‑counter drugs and herbal products. Some medicines can interact with Sprycel and may require adjustments to your treatment plan.
Sprycel can cause serious side effects in some people. Your doctor will monitor for changes in blood tests, liver function, and heart health during treatment. This helps to detect problems early and manage them promptly.
One of the most important considerations is the effect on blood cell counts. A decrease in red or white blood cells can increase the risk of anaemia or infection. Regular blood tests are used to check these levels during treatment.
Respiratory and lung problems can occur in some patients. Inform your doctor if you develop new or worsening breathing difficulties, a persistent cough, or chest discomfort. Seek urgent medical help if breathing becomes suddenly hard or you have severe symptoms.
Sprycel can affect the heart or blood vessels in rare cases. If you experience chest pain, fainting, dizziness, or swelling in the legs, tell your clinician as soon as possible. If you notice yellowing of the skin or eyes, dark urine, or persistent nausea, contact a healthcare professional promptly to assess liver health.
Like many medicines, Sprycel can cause side effects. The most common ones include tiredness, fever, loss of appetite, nausea, diarrhoea, vomiting, mouth ulcers, skin rashes, swelling, or cough. These are not experienced by everyone, and some people may only have mild effects.
Some patients may notice changes in liver function tests or a yellowing of the skin or eyes. If you have dark urine, pale stools, or upper abdominal pain, seek medical advice promptly to check liver health.
Sprycel can lead to low blood counts, which may cause easy bruising or more frequent infections. If you notice unusual bruising, bleeding from the nose or gums, or signs of infection, contact your clinician promptly.
Less common but more serious side effects can include breathing problems, severe abdominal pain, or severe skin reactions. If you develop any new or worsening symptoms, contact your healthcare team without delay and seek urgent medical help if needed.
Tell your clinician about all medicines you take, including vitamins, minerals, herbal supplements, and over‑the‑counter products. Some medicines can interact with Sprycel and may change how it works or increase the chance of side effects.
Medicines that can interact include those affecting the heart rhythm, certain antibiotics and antifungals, and some medicines used to treat HIV or hepatitis C. If you are prescribed any of these, your doctor may adjust Sprycel dosing or choose a different treatment.
Herbal products such as St John’s wort can interact with Sprycel. Do not start or stop herbal medicines without discussing them with a pharmacist or doctor.
If you are planning surgery or a medical procedure, inform the medical team that you are taking Sprycel. They will consider how the treatment might affect bleeding risk and wound healing and adjust plans if needed.
Sprycel may harm an unborn baby. Female patients should use effective contraception during treatment and for a period after finishing therapy as advised by the clinician. Discuss contraception options with your doctor to choose the most appropriate method for you.
If pregnancy is planned or becomes possible during treatment, seek medical advice promptly. Your clinician can explain potential risks and discuss options for care.
Breastfeeding during Sprycel treatment is generally not recommended, as the medicine can pass into breast milk. If you are breastfeeding or plan to breastfeed, speak with your healthcare professional about the best approach.
Fertility and pregnancy plans should be discussed with a clinician, who can provide guidance based on your health and treatment goals. Do not make changes to contraception or pregnancy plans without medical advice.
The following common questions relate to practical aspects of using Sprycel. For any concerns about your own treatment, contact your healthcare team for personalised guidance.
Answers here offer general information and should not replace professional medical advice. If you have questions about dosing, changes to your plan, or specific side effects, speak with your clinician or a pharmacist.
Always refer to the patient information leaflet and your healthcare team for the most accurate guidance relevant to you. This page is intended to support understanding and safe use of Sprycel in routine care.
If you notice any new or worsening symptoms, contact your clinician promptly. Seek urgent medical help if you have severe symptoms such as trouble breathing, chest pain, or severe allergic reactions.
Sprycel may affect blood test results and symptoms over weeks to months. The exact time to noticeable improvement varies by person and cancer type. Your doctor will monitor progress with tests and examinations and discuss what to expect.
If you miss a dose, contact your clinician for advice. Do not double up unless advised. If you are unsure what to do, ask your pharmacist or doctor for guidance before taking the next dose.
Sprycel can be used as part of a broader treatment plan that may include other medicines or therapies. Any changes to treatment should be discussed with your doctor to understand potential interactions and the expected benefits.
If you develop a fever, signs of infection, or feel unusually unwell, contact your healthcare team. Some infections require prompt treatment and may necessitate adjustments to Sprycel therapy.
Moderate or occasional alcohol intake is not automatically forbidden, but alcohol can affect liver function and hydration. Discuss your alcohol use with your clinician to ensure it is safe for your situation and to avoid potential interactions.
Yes. Regular blood tests are commonly used to monitor blood counts, liver enzymes, and overall health during treatment. Your clinician will explain which tests are needed and how often they should be performed.
Store Sprycel at room temperature in its original packaging. Protect it from moisture and heat, and keep it out of reach of children. Do not use it after the expiry date shown on the packaging.
Pregnancy carries potential risks for the unborn child. If you could become pregnant while taking Sprycel, use effective contraception and discuss plans with your clinician. Do not conceive during treatment unless advised otherwise by a healthcare professional.
You can travel with Sprycel, but plan ahead. Keep the tablets in their original packaging, carry any required prescription documentation, and take extra supplies in case of travel delays. If you need to be admitted to hospital, inform the medical staff you are taking Sprycel.
Tell your doctor about all medicines you take, including vitamins, supplements, and herbal products. Share details of any medical conditions you have and any allergies. This helps the team assess safety and tailor treatment to you.
Seek immediate medical help if you experience severe symptoms such as trouble breathing, swelling of the face or throat, severe rash, or other signs of a serious reaction. Contact your clinician as soon as possible about any concerning symptoms.
This information draws on the patient information leaflet for Sprycel and standard guidance used in UK practice. It reflects general safety and usage considerations for dasatinib as a cancer therapy.
Additional information is drawn from typical nursing and pharmacy guidance used to support patients starting treatment with Sprycel in the United Kingdom. Always rely on the official leaflet provided with your medicine and the instructions given by your healthcare team.
For personalised advice, speak with your doctor or pharmacist. They can explain how Sprycel applies to your specific health needs and how to manage any side effects or interactions.
If there are any changes to product information, rely on the latest official materials from the manufacturer and national regulators. Your pharmacist can help interpret these changes for you.
14–21 days. Free from £151.83 .
5–9 days. £22.77
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.